Revolutionizing Point of Care Diagnostics
Immediate, Actionable, Affordable
Critical Need, Convenient Access
Chipcare is developing a highly versatile, multiplexed point-of-care in-vitro diagnostic platform to enable healthcare professionals to rapidly and accurately perform lab quality tests using easily collected samples to aid in the differential diagnosis and monitoring of a wide range of infectious diseases.
Unmet Need
Sexually Transmitted Infections (STIs) are at an all-time high and are increasing at unprecedented rates in all age groups.
Clinical Use
We are in late-stage development of a point-of-care in-vitro diagnostics platform for Infectious Diseases.
Advantages of our Platform
Chipcare’s initial focus is on Sexually Transmitted Infections (STIs) and Antimicrobial Resistance in North America and Europe, enabling Healthcare Professionals to diagnose and prescribe the right treatment in a single visit, significantly enhancing the overall quality of patient care.
- STI test is based on molecular testing, which includes PCR
- Test in 30 minutes and treat immediately thereafter
- Simple automated sample preparation on cartridge
- Encourage antibiotic stewardship by testing for antimicrobial resistance markers
- Detect up to numerous disease targets / markers simultaneously
- Sensitive analyte detection; comparable to centralized testing labs
- Shelf-stable, disposable cartridges - No refrigeration required
- Designed to be CLIA waived
About Us
Chipcare is a Toronto-based biotechnology company developing a highly versatile point-of-care (POC) diagnostic platform which will enable unparalleled sample-to-action workflow in the clinic.
Our Mission
To alleviate global disease burden and improve global health through novel and powerful diagnostic platforms.
Our Vision
To make the diagnosis and treatment of STIs more convenient and immediate.
Our Values
Our values are centered around the needs of patients, clinics, physicians, and partners. We think locally and globally.
Our Commitment
We come to work every day with the commitment to improving the health of each individual, driving science and restoring health.
Our Team
ChipCare currently employs 30+ people in downtown Toronto. The team brings together multiple engineering disciplines and assay development scientists with experience in product development and commercialization.
ChipCare is registered to ISO 13485:2016 and maintains a licensed containment level 2 laboratory.